Betaxolol EP Impurity D
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

63659-16-5Betaxolol EP Impurity D

● In Stock

Catalogue No.:VL2940002
CAS No.:63659-16-5
Mol. Formula:C₁₂H₁₆O₂
Mol. Weight:192.25 g/mol

Additional information on CAS 63659-16-5

Parent drug

Betaxolol

IUPAC Name

4-[2-(Cyclopropylmethoxy)ethyl]phenol

Pharmacopoeial Synonyms

Betaxolol Phenol Analog

Other Synonyms

Phenol, 4-(2-(cyclopropylmethoxy)ethyl)-;

Smiles

C1CC1COCCC2=CC=C(C=C2)O

InChI

InChI=1S/C12H16O2/c13-12-5-3-10(4-6-12)7-8-14-9-11-1-2-11/h3-6,11,13H,1-2,7-9H2

Description

Betaxolol EP Impurity D (Free Base), also known as Betaxolol Phenol Analog, in various pharmacopoeias, is a highly characterized standard. It meets strict regulatory requirements set by USP, EMA, JP, and BP, making it a crucial component in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Betaxolol. To ensure precision and reliability in analytical applications, this impurity standard is supplied with a detailed Structure Elucidation Report (SER), offering valuable insights for method development and quality control. Betaxolol EP Impurity D ( CAS No: 63659-16-5 ) or 4-[2-(Cyclopropylmethoxy)ethyl]phenol is associate impurity of Betaxolol.Betaxolol is a competitive, beta(1)-selective (cardioselective) adrenergic antagonist. Betaxolol is used to treat hypertension, arrhythmias, coronary heart disease, glaucoma, and is also used to reduce non-fatal cardiac events in patients with heart failure.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url